USANA Health Sciences, Inc. (USNA) Cut to “Hold” at BidaskClub

BidaskClub downgraded shares of USANA Health Sciences, Inc. (NYSE:USNA) from a buy rating to a hold rating in a research report released on Tuesday.

Other equities research analysts have also issued reports about the stock. Pivotal Research raised shares of USANA Health Sciences from a hold rating to a buy rating and upped their price objective for the company from $55.00 to $75.00 in a research note on Wednesday, May 3rd. Zacks Investment Research raised shares of USANA Health Sciences from a sell rating to a hold rating in a research note on Wednesday, April 12th.

USANA Health Sciences (USNA) opened at 64.55 on Tuesday. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of 16.30 and a beta of 1.10. The company has a 50-day moving average of $64.08 and a 200 day moving average of $60.66. USANA Health Sciences has a one year low of $52.55 and a one year high of $75.00.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, May 2nd. The company reported $0.91 EPS for the quarter, missing the Zacks’ consensus estimate of $0.92 by $0.01. USANA Health Sciences had a net margin of 9.71% and a return on equity of 31.84%. The firm had revenue of $255.32 million during the quarter. On average, analysts anticipate that USANA Health Sciences will post $3.95 EPS for the current year.

TRADEMARK VIOLATION WARNING: “USANA Health Sciences, Inc. (USNA) Cut to “Hold” at BidaskClub” was reported by BBNS and is the property of of BBNS. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://baseballnewssource.com/markets/usana-health-sciences-inc-usna-cut-to-hold-at-bidaskclub/1094818.html.

In other USANA Health Sciences news, insider Paul A. Jones sold 9,851 shares of the company’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $64.50, for a total transaction of $635,389.50. Following the transaction, the insider now owns 6,020 shares in the company, valued at $388,290. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Myron W. Wentz sold 40,000 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $64.99, for a total transaction of $2,599,600.00. The disclosure for this sale can be found here. Insiders have sold a total of 174,735 shares of company stock worth $10,349,724 in the last quarter. 53.20% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. increased its position in USANA Health Sciences by 107.2% in the first quarter. Goldman Sachs Group Inc. now owns 56,373 shares of the company’s stock valued at $3,247,000 after buying an additional 29,162 shares during the last quarter. Tudor Investment Corp ET AL increased its position in USANA Health Sciences by 33.6% in the first quarter. Tudor Investment Corp ET AL now owns 14,818 shares of the company’s stock valued at $854,000 after buying an additional 3,727 shares during the last quarter. Highbridge Capital Management LLC acquired a new position in USANA Health Sciences during the first quarter valued at $254,000. Schwab Charles Investment Management Inc. increased its position in USANA Health Sciences by 3.6% in the first quarter. Schwab Charles Investment Management Inc. now owns 124,961 shares of the company’s stock valued at $7,198,000 after buying an additional 4,297 shares during the last quarter. Finally, Lucus Advisors LLC acquired a new position in USANA Health Sciences during the first quarter valued at $284,000. Hedge funds and other institutional investors own 44.26% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.